Pharmacodynamics and Drug Targets

This lecture covers the principles of pharmacodynamics, including binding interactions and quantitative description of ligand-receptor binding. It also explores various drug targets such as receptors, enzymes, ion channels, and protein therapeutics, along with their mechanisms of action. The instructor discusses the renin-angiotensin system, ACE inhibitors, and the comparison of different diuretics. Additionally, the lecture addresses the synthesis of Angiotensin II, the effects of Enalapril and Losartan, and typical exam questions related to drug efficacy and potency.

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related lectures (4)

Related concepts (47)

BIO-478: Pharmacology and pharmacokinetics

This course introduces the student to the fudamentals of pharmacology, pharmacokinetics and drug-receptor interactions. It discusses also pharmacogenetics and chronopharmacology, to exemplify the chal

ACE inhibitor

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a class of medication used primarily for the treatment of high blood pressure and heart failure. This class of medicine works by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart. ACE inhibitors inhibit the activity of angiotensin-converting enzyme, an important component of the renin–angiotensin system which converts angiotensin I to angiotensin II, and hydrolyses bradykinin.

Enzyme inhibitor

An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity. Enzymes are proteins that speed up chemical reactions necessary for life, in which substrate molecules are converted into products. An enzyme facilitates a specific chemical reaction by binding the substrate to its active site, a specialized area on the enzyme that accelerates the most difficult step of the reaction.

Drug discovery

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered by identifying the active ingredient from traditional remedies or by serendipitous discovery, as with penicillin. More recently, chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that had a desirable therapeutic effect in a process known as classical pharmacology.

Renin inhibitor

Renin inhibitors are pharmaceutical drugs inhibiting the activity of renin that is responsible for hydrolyzing angiotensinogen to angiotensin I, which in turn reduces the formation of angiotensin II that facilitates blood pressure. Renin inhibitor is often preceded by direct, called direct renin inhibitor in order to distinguish its mechanism from other renin–angiotensin–aldosterone system-interfering drugs such as angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs) and aldosterone receptor antagonists.

Biological target

A biological target is anything within a living organism to which some other entity (like an endogenous ligand or a drug) is directed and/or binds, resulting in a change in its behavior or function. Examples of common classes of biological targets are proteins and nucleic acids. The definition is contcan refer to the biological target of a pharmacologically active drug compound, the receptor target of a hormone (like insulin), or some other target of an external stimulus.

Pharmacological Targets and Interventions BIO-478: Pharmacology and pharmacokinetics

Explores targets for drug action and the design of specific inhibitors.

Pharmacology: Transporters & Protein Therapeutics BIO-478: Pharmacology and pharmacokinetics

Explores drug targets, protein therapeutics, and anti-TNF agents in pharmacology.

Drug Targets: Receptors, Enzymes, and Therapeutics BIO-478: Pharmacology and pharmacokinetics

Explores drug targets, including receptors, enzymes, and therapeutics, covering pharmacodynamics, case studies on NSAIDs, diabetes, and drug toxicity.

Pharmacodynamics: Acid-sensing ion channels and Drug Targets BIO-478: Pharmacology and pharmacokinetics

Explores acid-sensing ion channels, drug targets, and ligand-receptor binding.